|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenues | |||||
| Total revenues, net of rebates and discounts (including transactions with related parties of US$17,270, US$15,963 and US$16,309 for the years ended December 31, 2023, 2024 and 2025, respectively) | |||||
| Taxes and surcharges | |||||
| Net revenues | |||||
| Costs of revenues (including transactions with related parties of US$39, nil and nil for the years ended December 31, 2023, 2024 and 2025, respectively) | |||||
| Gross profit | |||||
| Operating expenses | |||||
| Research and development expenses | |||||
| Sales and marketing expenses | |||||
| General and administrative expenses | |||||
| Impairment of goodwill | |||||
| Credit loss (expenses)/write-back, net | |||||
| Total operating expenses | |||||
| Operating (loss)/income | |||||
| Interest income | |||||
| Interest expense | |||||
| Other income, net | |||||
| Income/(loss) before income taxes | |||||
| Income tax (expenses)/benefits | |||||
| Net income for the year | |||||
| Less: net income/(loss) attributable to the non-controlling interests | |||||
| Net income attributable to Xunlei Limited | |||||
| Other comprehensive (loss)/income: Currency translation adjustments, net of tax | |||||
| Comprehensive income/(loss) | |||||
| Less: comprehensive income/(loss) attributable to non-controlling interests | |||||
| Comprehensive income/(loss) attributable to Xunlei Limited | |||||
| Income per share for common shares | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares used in calculating | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...